{
    "2018-02-12": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Bristol-Myers Squibb’s Oncology Portfolio in 4Q17",
                "features": {
                    "keywords": [
                        "Bristol-Myers",
                        "Squibb",
                        "Oncology",
                        "Portfolio",
                        "4Q17"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Can Jakafi Performance Drive Incyte's (INCY) Q4 Earnings?",
                "features": {
                    "keywords": [
                        "Jakafi",
                        "Performance",
                        "Incyte",
                        "Q4",
                        "Earnings"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-01",
                "original_text": "Analyst Recommendations for Amgen in February 2018",
                "features": {
                    "keywords": [
                        "Analyst",
                        "Recommendations",
                        "Amgen",
                        "February",
                        "2018"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-29",
                "original_text": "What’s Pfizer’s Valuation after 4Q17 Earnings?",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Valuation",
                        "4Q17",
                        "Earnings"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-15",
                "original_text": "[$$] Buying United, Selling Lilly, Rambus, Tronc",
                "features": {
                    "keywords": [
                        "Buying",
                        "United",
                        "Selling",
                        "Lilly",
                        "Rambus",
                        "Tronc"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "technology",
                        "media"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-10",
                "original_text": "Today’s Research Reports on Trending Tickers: Eli Lilly and Company and Pfizer",
                "features": {
                    "keywords": [
                        "Research",
                        "Reports",
                        "Trending",
                        "Tickers",
                        "Eli",
                        "Lilly",
                        "Pfizer"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-12",
                "original_text": "See what the IHS Markit Score report has to say about Eli Lilly And Co.",
                "features": {
                    "keywords": [
                        "IHS",
                        "Markit",
                        "Score",
                        "report",
                        "Eli",
                        "Lilly",
                        "Co."
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-18",
                "original_text": "Better Buy: Pfizer Inc. (PFE) vs. Eli Lilly (LLY)",
                "features": {
                    "keywords": [
                        "Better",
                        "Buy",
                        "Pfizer",
                        "Inc.",
                        "Eli",
                        "Lilly"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}